WuXi AppTec Co., Ltd. (WUXIF)
OTCMKTS
· Delayed Price · Currency is USD
8.12
+1.96 (31.82%)
Feb 20, 2025, 3:00 PM EST
WuXi AppTec Revenue
WuXi AppTec had revenue of 10.46B CNY in the quarter ending September 30, 2024, a decrease of -1.96%. This brings the company's revenue in the last twelve months to 38.50B, down -4.94% year-over-year. In the year 2023, WuXi AppTec had annual revenue of 40.34B with 2.51% growth.
Revenue (ttm)
38.50B CNY
Revenue Growth
-4.94%
P/S Ratio
n/a
Revenue / Employee
936.41K CNY
Employees
41,116
Market Cap
27.09B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.34B | 986.03M | 2.51% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | 12.87B | 3.26B | 33.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
WuXi AppTec News
- 5 weeks ago - WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI) - PRNewsWire
- 7 weeks ago - WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year - PRNewsWire
- 3 months ago - WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating - PRNewsWire
- 4 months ago - WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year - PRNewsWire
- 4 months ago - Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY - PRNewsWire
- 4 months ago - WuXi AppTec to raise $500 mln in convertible bond sale as US restrictions loom - Reuters
- 5 months ago - US bill to restrict business with China's WuXi AppTec, BGI passes House - Reuters
- 10 months ago - US House committee to vote on bill to restrict BGI, WuXi AppTec - Reuters